| abstract |
The invention relates to glycogenphosphorylase inhibition compound having the formula and their pharmaceutically acceptable salts and promedicaments, to pharmaceutical compositions containing these inhibitors, and to their application for the treatment of diabetes, hyperglycaemia, hypercholesterolaemia, hypertension, hyperinsulinaemia, hyperlipidaemia, atherosclerosis and myocardial ischaemia in mammals. 38 claims |